Home Cart 0 Sign in  
X

[ CAS No. 578-57-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 578-57-4
Chemical Structure| 578-57-4
Chemical Structure| 578-57-4
Structure of 578-57-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 578-57-4 ]

Related Doc. of [ 578-57-4 ]

Alternatived Products of [ 578-57-4 ]

Product Details of [ 578-57-4 ]

CAS No. :578-57-4 MDL No. :MFCD00000064
Formula : C7H7BrO Boiling Point : -
Linear Structure Formula :- InChI Key :HTDQSWDEWGSAMN-UHFFFAOYSA-N
M.W : 187.03 Pubchem ID :11358
Synonyms :

Calculated chemistry of [ 578-57-4 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.63
TPSA : 9.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.2
Log Po/w (XLOGP3) : 2.86
Log Po/w (WLOGP) : 2.46
Log Po/w (MLOGP) : 2.57
Log Po/w (SILICOS-IT) : 2.52
Consensus Log Po/w : 2.52

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.23
Solubility : 0.11 mg/ml ; 0.000591 mol/l
Class : Soluble
Log S (Ali) : -2.71
Solubility : 0.362 mg/ml ; 0.00194 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.38
Solubility : 0.0783 mg/ml ; 0.000419 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.1

Safety of [ 578-57-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 578-57-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 578-57-4 ]
  • Downstream synthetic route of [ 578-57-4 ]

[ 578-57-4 ] Synthesis Path-Upstream   1~37

  • 1
  • [ 288-13-1 ]
  • [ 578-57-4 ]
  • [ 102908-37-2 ]
YieldReaction ConditionsOperation in experiment
51% With copper diacetate; sodium hydroxide; 3-(diphenylphosphino)propionic acid In 1,4-dioxane at 120℃; for 36 h; Sealed tube General procedure: Cu(OAc)2 (0.03mmol), L2 (0.06mmol), aryl idione or bromide (0.5mmol), 1H-pyrazole (0.75mmol), NaOH (1mmol), and 1,4-dioxane (1mL) was added into a 5mL tube, then sealed. The mixture was stirred at 100°C for certain time. After cooling to room temperature, the mixture was quenched with 10mL H2O and extracted with EtOAc (3×20mL). The combined EtOAc extracts were dried with anhydrous Na2SO4 and filtrated and the solvent was removed under reduced pressure. The residue was purified by flash column chromatography on silica gel with PE/EtOAc, as the eluent, to afford the desired products.
Reference: [1] Advanced Synthesis and Catalysis, 2007, vol. 349, # 17-18, p. 2673 - 2676
[2] Chinese Chemical Letters, 2014, vol. 25, # 5, p. 775 - 778
  • 2
  • [ 578-57-4 ]
  • [ 6850-57-3 ]
YieldReaction ConditionsOperation in experiment
19%
Stage #1: With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; water; caesium carbonate In 1,4-dioxane at 95℃;
Stage #2: With hydrazine In 1,4-dioxane; methanol at 20℃; for 1 h; Heating / reflux
To the mixture of 2-bromoanisole (0.020 ml, 0.16 mmol) and 1,4-dioxane (2 ml), water (0.2 ml), cesium carbonate (0.32 g, 0.97 mmol), sodium 1,3-dioxo-1,3-dihydro-isoindole-2-ylmethyl trifluoroborate (81 mg, 0.32 mmol), palladium(II) acetate (3.6 mg, 0.016 mmol), and 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (13 mg, 0.032 mmol) were added, and then the obtained reaction mixture was stirred at 95° C. (an outer temperature) overnight. The reaction mixture was cooled to room temperature, and then hydrazine hydrate (0.039 ml, 0.81 mmol) and methanol (2 ml) were added thereto, followed by heating to reflux for 1 hour. The reaction mixture was cooled to room temperature, and then water and ethyl acetate were added to the reaction mixture, followed by filtration with celite. The organic layer of the filtrate was separated and washed with saline. The solvents were evaporated under reduced pressure from the organic layer, and then the obtained residue was purified with NH-silica gel column chromatography (heptane:ethyl acetate=1:4), thereby obtaining the entitled compound (4.1 mg, 19percent) as the mixture with 2'-(dicyclohexyl-phosphinoyl)-2,6-dimethoxy-biphenyl (6.2 mg). 1H-NMR Spectrum (CDCl3) δ(ppm): 3.81(2H, s), 3.85(3H, s), 6.87(1H, d, J=8.1 Hz), 6.91(1H, dt, J=1.1, 7.3 Hz), 7.20-7.25(2H, m)
Reference: [1] Patent: US2008/15351, 2008, A1, . Location in patent: Page/Page column 14
  • 3
  • [ 578-57-4 ]
  • [ 19056-41-8 ]
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 3, p. 563 - 567
  • 4
  • [ 578-57-4 ]
  • [ 2398-37-0 ]
  • [ 591-20-8 ]
Reference: [1] Patent: US4447660, 1984, A,
  • 5
  • [ 1072-53-3 ]
  • [ 578-57-4 ]
  • [ 7417-18-7 ]
Reference: [1] Synthesis, 2008, # 11, p. 1793 - 1797
  • 6
  • [ 578-57-4 ]
  • [ 75-36-5 ]
  • [ 35310-75-9 ]
YieldReaction ConditionsOperation in experiment
12.1% With o-tetrachloroquinone; (η5,η5-(C5H4)2SiMe2)Mo2(CO)6 In 1,2-dichloro-ethane at 80℃; for 24 h; Inert atmosphere; Schlenk technique General procedure: Under an argon atmosphere, the monobridged bis(cyclopentadienyl)molybdenum carbonyl complex (0.1 mmol) and o-chloranil (0.098 g, 0.4 mmol) were mixed with 1,2-dichloroethane (3.5 mL)in a 25 mL round-bottom flask at room temperature with magneticstirring. The solution was immediately darkened. After the mixturehad been stirred for 40 min at room temperature, aromatic compoundsand acylation reagents were added by syringe. The reactionmixture was heated at 80 °C in an oil bath for 24 h. After cooling toroom temperature, the solvent was removed by rotary evaporation,and the residue was purified by Al2O3 column chromatography,eluting with petroleum ether developed colorless liquid thatafforded the corresponding white solid product. The catalyst wasrecovered and washed with petroleum ether, then reused forfurther cycles. The course of the reaction was monitored using anAgilent 6820 gas chromatograph.
Reference: [1] Marine Drugs, 2013, vol. 11, # 5, p. 1427 - 1439
[2] Polyhedron, 2018, vol. 147, p. 75 - 79
[3] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1947, vol. 224, p. 1363
  • 7
  • [ 578-57-4 ]
  • [ 108-24-7 ]
  • [ 35310-75-9 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 36, p. 6331 - 6333
[2] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 2, p. 971 - 977
[3] Journal of Organic Chemistry, 1993, vol. 58, # 6, p. 1385 - 1392
  • 8
  • [ 578-57-4 ]
  • [ 64-19-7 ]
  • [ 35310-75-9 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 39, p. 9201 - 9209
  • 9
  • [ 3984-22-3 ]
  • [ 578-57-4 ]
  • [ 6342-77-4 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 50, p. 11533 - 11540
  • 10
  • [ 578-57-4 ]
  • [ 10130-87-7 ]
Reference: [1] Journal of Organic Chemistry, 2003, vol. 68, # 21, p. 8274 - 8276
  • 11
  • [ 578-57-4 ]
  • [ 28165-49-3 ]
  • [ 135999-16-5 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 15, p. 4291 - 4296
  • 12
  • [ 578-57-4 ]
  • [ 5197-28-4 ]
  • [ 98775-19-0 ]
Reference: [1] Journal of the American Chemical Society, 1934, vol. 56, p. 1787,1790
  • 13
  • [ 578-57-4 ]
  • [ 5197-28-4 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1897, vol. <3> 17, p. 115
[2] Chemische Berichte, 1896, vol. 29, p. 2598[3] Chemische Berichte, 1899, vol. 32, p. 161 Anm.
  • 14
  • [ 578-57-4 ]
  • [ 7697-37-2 ]
  • [ 64-19-7 ]
  • [ 5197-28-4 ]
Reference: [1] Chemische Berichte, 1896, vol. 29, p. 2598[2] Chemische Berichte, 1899, vol. 32, p. 161 Anm.
  • 15
  • [ 578-57-4 ]
  • [ 6322-83-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 106, p. 50 - 59
  • 16
  • [ 578-57-4 ]
  • [ 7439-89-6 ]
  • [ 19056-40-7 ]
Reference: [1] Patent: US2003/158179, 2003, A1,
  • 17
  • [ 578-57-4 ]
  • [ 4731-65-1 ]
Reference: [1] Journal of the American Chemical Society, 1975, vol. 97, # 7, p. 1787 - 1794
[2] Dalton Transactions, 2012, vol. 41, # 15, p. 4552 - 4557
[3] Patent: US8309779, 2012, B2, . Location in patent: Page/Page column 18
  • 18
  • [ 578-57-4 ]
  • [ 4731-65-1 ]
Reference: [1] Patent: US5663426, 1997, A,
  • 19
  • [ 578-57-4 ]
  • [ 593-51-1 ]
  • [ 10541-78-3 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 17, p. 4388 - 4391
  • 20
  • [ 578-57-4 ]
  • [ 74-89-5 ]
  • [ 10541-78-3 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 4, p. 1180 - 1183
  • 21
  • [ 5720-06-9 ]
  • [ 578-57-4 ]
  • [ 21702-84-1 ]
  • [ 89694-45-1 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 2, p. 566 - 569
  • 22
  • [ 578-57-4 ]
  • [ 23094-96-4 ]
YieldReaction ConditionsOperation in experiment
98% With chlorosulfonic acid In dichloromethane at -5 - 20℃; for 1.5 h; L-BROMO-2-METHOXY-BENZENE (1.87 g, 10.0 mmol) was dissolved in chloroform (5 mL) and the solution was cooled in an ice-salt bath to-5° C to 0° C. The cooled solution was carefully charged with CHLOROSULFONIC acid (2.0 mL, 30.0 mmol) over 30 minutes and the mixture was allowed to warm to room temperature over 1 hour. The mixture then was poured onto chopped ice and transferred to a separatory funnel. The aqueous layer was separated and extracted (X2). The combined organic layers were dried and concentrated to give 3-bromo-4-methoxyphenylsulfonyl chloride (2.80 g, 98percent). 3-Bromo-4-methoxyphenylsulfonyl chloride (2.80 g, 9.8 mmol) was dissolved in dichloromethane (30 mL) and the solution was treated with triethylamine (1.76 mL, 12.6 mmol), followed by the dropwise addition of t-butylamine (1.33 mL, 12.6 mmol). The mixture was allowed to stand for 2 hours and then was poured onto a mixture of 5percent citric acid solution and dichloromethane. The organic layer was separated and the aqueous layer was extracted with dichloromethane/ (X2). The combined organic layers were dried and concentrated. Crystallization of the crude solid from ethyl acetate/hexane gave 3-BROMO-N- tert-butyl-4-methoxybenzenesulfonamide (2.43 g, 77percent)
98% With chlorosulfonic acid In chloroform at -7 - 20℃; for 1.5 - 1.83333 h; o-Bromoanisole (1.87 g, 10. OMMOL) was dissolved in chloroform (5 mL) and the solution was cooled in an ice-salt bath to-5° C to 0° C. The solution was carefully charged with CHLOROSULFONIC acid (2.0 mL, 30.0 mmol) over 30 minutes and then allowed to warm to room temperature over 1 hour. The mixture was poured onto chopped ice and transferred to separatory funnel. The organic layer was separated and the aqueous layer was extracted, dried and concentrated to give 3-bromo-4-methoxyphenylsulfonyl chloride (2.80 g, 98percent).; REFERENCE 17 N-TERT-BUTYL-4-METHOXY-3- (4, 4,5, 5-TETRAMETHYL- [1, 3,2] DIOXABOROLAN-2-YL) -
BENZENESULFONAMIDE [0214] A 500 mL 3-necked flask, equipped with thermometer, overhead stirrer and a 60 mL DROPPING FUNNEL, WAS CHARGED WITH 2-BROMOANISOLE (46.8 G, 0.25 MOL, 1.0 EQ. ) AND ANHYDROUS chloroform (250 mL). The flask was flushed with nitrogen and cooled with a brine-ice cool- bath to an internal temperature of-7°C and then chlorosulfonic acid (87.4 g, 0.75 mol, 3.0 EQ.) was added via dropping funnel over 1 hour while maintaining an internal temperature of less THAN-5°C. The reaction mixture was stirred for 50 minutes and then poured on to ice (500 g). The mixture was stirred until the ice melted and then the organic layer was separated and washed with water (2 x 200 mL). The combined aqueous layers were backwashed with chloroform (2 x 200 mL) and the combined organic phases were washed with brine and dried (MGS04). [0215] The organic phase was treated at room temperature with triethylamine (87 mL, 63 g, 0.625 MOL, 2.5 EQ. ) AND THEN TERT-BUTYLAMINE (34 ML, 24 G, 0.325 MOL, 1.3 EQ. ). THE REACTION mixture was stirred overnight, cooled in an ice-bath and poured into ice cold 2M hydrochloric acid (500 mL). The organic layer was separated and washed with 2M hydrochloric acid (2 x 250 mL) and brine, dried (MGSO4) and concentrated. Crystallization of the residue from chloroform-hexane gave 3-BROMO-N-TERT-BUTYL-4-METHOXY-BENZENESULFONAMIDE (37.5 g, 47percent) as brilliant white crystals. RP-HPLC (10-95S) RT = 3.92 MIN.APOS;H NMR (400 MHz, d6- DMSO): 8 7. 94 (1H, d, J = 2. 4 HZ), 7.77 (1H, dd, J = 8. 8,2. 4 HZ), 7.48 (1H, s), 7.25 (1H, d, 8.8 Hz), 3.92 (3H, s), 1.08 (9H, s). [0216] A mixture OF 3-BROMO-N-TERT-BUTYL-4-METHOXY-BENZENESULFONAMIDE (36.2 g, 112 mmol, 1.0 eq), bis (pinocalto) diborane (30.0 g, 117 mmol, 1.05 EQ.), potassium acetate (33.0 G, 336 MMOL, 3.0 EQ. ) AND PDCL2 (DPPF)-DCM (533 MG, 0.653 MMOL, 5.8 MOL percent, IN 115 ML of 1,4-dioxane) was heated at 100 °C under nitrogen and then 4,4, 5,5, 4', 4', 5', 5'- OCTAMETHYL- [2, 2APOS;] BI [ [1, 3, 2] DIOXABOROLANYL] (0.35 EQ. ) WAS ADDED TO THE MIXTURE. THE REACTION mixture was heated for 28 hours and then allowed to cool. The mixture was filtered of solids and concentrated. The residue was dissolved in ethyl acetate (500 mL) and the solution was washed with 5percent citric acid (3x 200 mL), saturated sodium bicarbonate (3 x 200 mL) and then brine, dried (MGSO4) and concentrated. Purification of product from the residue by silica-gel chromatography, eluting with 10-50percent EtOAc/Hex gave N-tert-butyl-4-methoxy-3- (4, 4,5, 5- TETRAMETHYL- [1, 3,2] DIOXABOROLAN-2-YL) -BENZENESULFONAMIDE (30 G, 72percent) AS A PALE-ORANGE solid. RP-HPLC (10-95S): RT = 3.17 min.'HNMR (400MHz, d6-DMSO) : 57. 95 (1H, d, J = 2.4 Hz), 7.85 (1H, dd, J = 8.8, 2.4 Hz), 7.36 (1H, s), 7.11 (1H, d, J = 8.8), 3.81 (3H, s), 1.29 (12H, s), 1.07 (9H, s); M/Z (LCMS-ESI): Q+ 310 (boronic acid+Na), 370 (M+H), 392 (M+Na); Q~ 354 (M-Me), 556 (boronic acid anhydride).
97% With chlorosulfonic acid In dichloromethane at 0 - 20℃; Cooling with ice A solution of 2-bromoanisole (5.00 g, 26.7 mmol) in CH2Cl2 (100 mL) was cooled on ice. Chlorosulfonic acid (9.3 g, 80 mmol) in CH2Cl2 (100 mL) was added dropwise at 0° C. The reaction mixture was allowed to reach room temperature overnight and was then added slowly to a stirred solution of brine. The organic phase was separated and washed with brine, dried over MgSO4, filtered and concentrated. The intermediate 3-bromo-4-methoxybenzenesulfonyl chloride was obtained in 97percent yield (7.33 g). 1H NMR (600 MHz, CDCl3) δ ppm 4.03 (s, 3H) 7.04 (d, J=8.85 Hz, 1H) 7.99 (dd, J=8.85, 2.44 Hz, 1H) 8.22 (d, J=2.44 Hz, 1H). MS (ESI+) m/z 249 [M-Cl]+.
Reference: [1] Patent: WO2004/50637, 2004, A2, . Location in patent: Page 68-69
[2] Patent: WO2004/62661, 2004, A1, . Location in patent: Page/Page column 24-25; 37-38
[3] Patent: US2015/25068, 2015, A1, . Location in patent: Paragraph 0794
[4] Journal of the Chemical Society [Section] C: Organic, 1969, p. 1341 - 1345
[5] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 4, p. 485 - 488
  • 23
  • [ 578-57-4 ]
  • [ 116557-46-1 ]
Reference: [1] Journal of the American Chemical Society, 1934, vol. 56, p. 1787,1790
  • 24
  • [ 578-57-4 ]
  • [ 60633-25-2 ]
Reference: [1] Chemical Science, 2017, vol. 8, # 10, p. 7009 - 7013
  • 25
  • [ 578-57-4 ]
  • [ 172217-13-9 ]
  • [ 158966-62-2 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1995, vol. 43, # 8, p. 1287 - 1293
  • 26
  • [ 578-57-4 ]
  • [ 182056-39-9 ]
YieldReaction ConditionsOperation in experiment
92% With N-iodo-succinimide; [bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) In dichloromethane; toluene at 20℃; for 14 h; General procedure: To a stirred solution of the substrate (1 mmol) in CH2Cl2 or (CH2Cl)2 (0.1 M) were added Ph3PAuNTf2 (0.025 mmol, 19 mg; complex Ph3PAuNTf2 toluene, 2:1) followed by N-iodosuccinimide (1.1 mmol, 248 mg). The resulting solution was stirred at r.t. or under reflux until complete conversion of the starting material. After removal of the solvent under reduced pressure, the crude material was purified by flash column chromatography using different gradients of hexanes and EtOAc to obtain the pure desired products.
Reference: [1] Synlett, 2014, vol. 25, # 3, p. 399 - 402
[2] Synthetic Communications, 2007, vol. 37, # 8, p. 1259 - 1265
[3] Canadian Journal of Chemistry, 2005, vol. 83, # 10, p. 1808 - 1811
[4] Tetrahedron Letters, 2004, vol. 45, # 43, p. 8015 - 8018
  • 27
  • [ 578-57-4 ]
  • [ 5197-28-4 ]
  • [ 98775-19-0 ]
Reference: [1] Journal of the American Chemical Society, 1934, vol. 56, p. 1787,1790
  • 28
  • [ 578-57-4 ]
  • [ 5464-78-8 ]
Reference: [1] Patent: WO2011/72174, 2011, A1,
[2] Patent: WO2012/3418, 2012, A2,
  • 29
  • [ 578-57-4 ]
  • [ 113411-62-4 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1987, vol. 24, p. 1317 - 1319
  • 30
  • [ 578-57-4 ]
  • [ 28165-49-3 ]
  • [ 135999-16-5 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 15, p. 4291 - 4296
  • 31
  • [ 578-57-4 ]
  • [ 135999-16-5 ]
  • [ 90-05-1 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 15, p. 4291 - 4296
  • 32
  • [ 578-57-4 ]
  • [ 118486-94-5 ]
  • [ 38527-59-2 ]
Reference: [1] Green Chemistry, 2013, vol. 15, # 1, p. 105 - 109
  • 33
  • [ 110-00-9 ]
  • [ 578-57-4 ]
  • [ 38527-59-2 ]
Reference: [1] Chemistry - A European Journal, 2009, vol. 15, # 39, p. 10280 - 10290
  • 34
  • [ 578-57-4 ]
  • [ 666841-74-3 ]
Reference: [1] Farmaco, 2003, vol. 58, # 9, p. 851 - 858
  • 35
  • [ 578-57-4 ]
  • [ 777061-38-8 ]
  • [ 642494-36-8 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6812 - 6820
  • 36
  • [ 578-57-4 ]
  • [ 777061-36-6 ]
  • [ 269410-24-4 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6812 - 6820
  • 37
  • [ 578-57-4 ]
  • [ 87199-17-5 ]
  • [ 421553-62-0 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 41, p. 5858 - 5862
[2] New Journal of Chemistry, 2004, vol. 28, # 5, p. 600 - 605
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 578-57-4 ]

Honokiol Related Intermediates

Chemical Structure| 29415-97-2

[ 29415-97-2 ]

Methyl 3-bromo-4-hydroxybenzoate

Chemical Structure| 89-55-4

[ 89-55-4 ]

5-Bromo-2-hydroxybenzoic acid

Chemical Structure| 73183-34-3

[ 73183-34-3 ]

4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)

Chemical Structure| 4068-76-2

[ 4068-76-2 ]

Methyl 5-bromo-2-hydroxybenzoate

Chemical Structure| 99-96-7

[ 99-96-7 ]

4-Hydroxybenzoic acid

Related Functional Groups of
[ 578-57-4 ]

Aryls

Chemical Structure| 17715-69-4

[ 17715-69-4 ]

1-Bromo-2,4-dimethoxybenzene

Similarity: 0.97

Chemical Structure| 95970-08-4

[ 95970-08-4 ]

2,5-Dibromoanisole

Similarity: 0.97

Chemical Structure| 102127-34-4

[ 102127-34-4 ]

4-Bromo-3-methoxyphenol

Similarity: 0.97

Chemical Structure| 17332-11-5

[ 17332-11-5 ]

2-Bromo-4-methoxyphenol

Similarity: 0.97

Chemical Structure| 5030-61-5

[ 5030-61-5 ]

2,3-Dibromo-1,4-dimethoxybenzene

Similarity: 0.95

Bromides

Chemical Structure| 17715-69-4

[ 17715-69-4 ]

1-Bromo-2,4-dimethoxybenzene

Similarity: 0.97

Chemical Structure| 95970-08-4

[ 95970-08-4 ]

2,5-Dibromoanisole

Similarity: 0.97

Chemical Structure| 102127-34-4

[ 102127-34-4 ]

4-Bromo-3-methoxyphenol

Similarity: 0.97

Chemical Structure| 17332-11-5

[ 17332-11-5 ]

2-Bromo-4-methoxyphenol

Similarity: 0.97

Chemical Structure| 5030-61-5

[ 5030-61-5 ]

2,3-Dibromo-1,4-dimethoxybenzene

Similarity: 0.95

Ethers

Chemical Structure| 17715-69-4

[ 17715-69-4 ]

1-Bromo-2,4-dimethoxybenzene

Similarity: 0.97

Chemical Structure| 95970-08-4

[ 95970-08-4 ]

2,5-Dibromoanisole

Similarity: 0.97

Chemical Structure| 102127-34-4

[ 102127-34-4 ]

4-Bromo-3-methoxyphenol

Similarity: 0.97

Chemical Structure| 17332-11-5

[ 17332-11-5 ]

2-Bromo-4-methoxyphenol

Similarity: 0.97

Chemical Structure| 5030-61-5

[ 5030-61-5 ]

2,3-Dibromo-1,4-dimethoxybenzene

Similarity: 0.95